BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Nov 30, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-11-25

Reporting Person: FUCHS HENRY J (President, Worldwide R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-25	Common Stock	M	15000	$26.49	Acquired	128878	Direct
2016-11-25	Common Stock	S	15000	$87.3992	Disposed	113878	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-25	Stock Option (Right to buy Common Stock)	$26.49	M	15000	Disposed	2021-05-11	Common Stock (15000)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on May 12, 2016.

F2: The price in column 4 is the weighted average price. The price actually received ranged from $86.67 to $88.06. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.